To assess the in vivo therapeutic activity of AGI-6780 against TNBC, we tested the effects of AGI-6780 in a xenograft tumor model. MDA-MB-231 cells were injected orthotopically into the mammary glands of nude mice. After the tumors reached 5–6 mm in diameter, the mice were randomly ...